TMDXNasdaq United StatesHealth CareBiotechnology: Electromedical & Electrotherapeutic Apparatus
Market cap
$2.909 B
$83.89 +4.59%
Close of 7 Aug 2026
Revenue
$605.5M
#1819 by revenue
Earnings
$190.3M
#1027 by earnings
Shares outstanding
34,675,145
Latest filing cover page
P/E ratio
15.3
Cap ÷ net income
Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap
All 28 →Where these numbers come from
Share counts and financials for TransMedics Group are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.